Update on successes and challenges regarding mother-to-child transmission of HIV

Current Opinion in Pediatrics

Volumn 21, Issue 1, 2009, Pages 94-101

  Paintsil, Elijah ^a   Andiman, Warren A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral drugs; Drug resistant virus; HIV; Prevention of mother to child transmission; Resource limited setting; Resource rich setting

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE;

AFRICA; DISEASE TRANSMISSION; DRUG EFFICACY; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALARIA; MIXED INFECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SHORT COURSE THERAPY; SINGLE DRUG DOSE;

ADULT; ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DRUG RESISTANCE, VIRAL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOTHER-CHILD RELATIONS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTIVE HEALTH SERVICES; RISK FACTORS; TREATMENT OUTCOME; WORLD HEALTH;

EID: 62849107032     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32831ec353     Document Type: Review

References (44)

1. Report on the global AIDS epidemic: executive summary 2008. http://data.unaids.org/pub/GlobalReport/2008/JC1511_GR08_ExecutiveSummary_en. pdf. [Accessed 13 September 2008]
2. Action Guide for the United Nations Country Teams. Implementing the Declaration of Commitment on HIV/AIDS. United Nations Special Session on HIV/AIDS; 2001. New York: United Nations General Assembly; 2001.
3. De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 2000;283:1175-1182.
4. Kourtis AP, Lee FK, Abrams EJ, et al. Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis 2006;11:726-732.
5. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study group. N Engl J Med 1994;331:1173-1180.
6. Stokes SH, McMaster P, Ismail KM. Acceptability of perinatal rapid point-of-care HIV testing in an area of low HIV prevalence in the UK. Arch Dis Child 2007;92:505-508.
7. Paintsil E, Andiman WA. Care and management of the infant of the HIV-1-infected mother. Semin Perinatol 2007;31:112-123.
8. Mofenson LM. Can perinatal HIV infection be eliminated in the United States? JAMA 1999;282:577-579.
9. HIV/AIDS Surveillance Report, 2005. Vol. 17. [Revised ed.] Atlanta: 2005. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2005report/. [Accessed 13 September 2008]
10. Jasseron C, Mandelbrot L, Tubiana R, et al. Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women? AIDS 2008;22:1503-1511.
11. Cunningham CK, Balasubramanian R, Delke I, et al. The impact of race/ethnicity on mother-to-child HIV transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316. J Acquir Immune Defic Syndr 2004;36:800-807.
12. Mbopi-Keou FX, Legotf J, Gresenguet G, et al. Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women. J Acquir Immune Defic Syndr 2003;33:121-124.
13. Cowan FM, Humphrey JH, Ntozini R, et al. Maternal herpes simplex virus type 2 infection, syphilis and risk of intra-partum transmission of HIV-1: results of a case control study. AIDS 2008;22:193-201.
14. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007;356:790-799.
15. Mofenson LM, Munderi P. Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants. J Acquir Immune Defic Syndr 2002;30:200-215.
16. Pacheco SE, McIntosh K, Lu M, et al. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: an analysis of the women and infants transmission study. J Infect Dis 2006;194:1089-1097.
17. Persaud D, Palumbo P, Ziemniak C, et al. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. J Infect Dis 2007;195:1402-1410.
18. Nolan M, Fowler MG, Mofenson LM. Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance. J Acquir Immune Defic Syndr 2002;30:216-229.
19. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004;351:217-228.
20. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infant: towards universal acess. Recommendations for a public health approach. 2006. http:/www.who.int/hiv/pub/ guidelines/pmtctguidelines3.pdf. [Accessed 13 September 2008]
21. Chigwedere P, Seage GR, Lee TH, Essex M. Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials. AIDS Res Hum Retroviruses 2008;24:827-837.
22. Boeke CE, Jackson JB. Estimate of infant HIV-free survival at 6 to 8 weeks of age due to maternal antiretroviral prophylaxis in sub-Saharan Africa, 2004-2005. J Int Assoc Physicians AIDS Care (Chic III) 2008;7:133-140.
23. Marazzi MC, Bartolo M, Emberti Gialloreti L, et al. Improving adherence to highly active antiretroviral therapy in Africa: the DREAM programme in Mozambique. Health Educ Res 2006;21:34-42.
24. Palombi L, Marazzi MC, Voetberg A, Magid NA. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS 2007;21 (Suppl 4):S65-S71.
25. Tonwe-Gold B, Ekouevi DK, Viho I, et al. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med 2007;4:e257.
26. Amornwichet P, Teeraratkul A, Simonds RJ, et al. Preventing mother-to-child HIV transmission: the first year of Thailand's national program. JAMA 2002;288:245-248.
27. Plipat T, Naiwatanakul T, Rattanasuporn N, et al. Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003: results from population-based surveillance in six provinces. AIDS 2007;21:145-151.
28. Leroy V, Ekouevi DK, Becquet R, et al. 18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission. PLoS ONE 2008;3:e1645.
29. Ginsburg AS, Hoblitzelle CW, Sripipatana TL, Wilfert CM. Provision of care following prevention of mother-to-child HIV transmission services in resource-limited settings. AIDS 2007;21:2529-2532.
30. Creek T, Ntumy R, Mazhani L, et al. Factors associated with low early uptake of a national program to prevent mother to child transmission of HIV (PMTCT): results of a survey of mothers and providers, Botswana, 2003. AIDS Behav 2007. doi: 10.1007/s10461-007-9322-8.
31. Nkonki LL, Doherty TM, Hill Z, et al. Missed opportunities for participation in prevention of mother to child transmission programmes: simplicity of nevirapine does not necessarily lead to optimal uptake, a qualitative study. AIDS Res Ther 2007;4:27.
32. Chandisarewa W, Stranix-Chibanda L, Chirapa E, et al. Routine offer of antenatal HIV testing ('opt-out' approach) to prevent mother-to-child transmission of HIV in urban Zimbabwe. Bull World Health Organ 2007;85:843-850.
33. Pai NP, Barick R, Tulsky JP, et al. Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India. PLoS Med 2008;5:e92.
34. Flys TS, Donnell D, Mwatha A, et al. Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission. J Infect Dis 2007;195:711-715.
35. Flys TS, Mwatha A, Guay LA, et al. Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine. AIDS 2007;21:2077-2082.
36. Chi BH, Sinkala M, Stringer EM, et al. Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine. AIDS 2007;21:957-964.
37. Lockman S, Shapiro RL, Smeaton LM, et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med 2007;356:135-147.
38. Arrive E, Newell ML, Ekouevi DK, et al. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol 2007;36:1009-1021.
39. Chi BH, Sinkala M, Mbewe F, et al. Single-dose tenofovir and emtricitabine for reduction of viral resistance to nonnucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. Lancet 2007;370:1698-1705.
40. Brahmbhatt H, Sullivan D, Kigozi G, et al. Association of HIV and malaria with mother-to-child transmission, birth outcomes, and child mortality. J Acquir Immune Defic Syndr 2008;47:472-476.
41. Atashili J, Kalilani L, Seksaria V, Sickbert-Bennett EE. Potential impact of infant feeding recommendations on mortality and HIV-infection in children born to HIV-infected mothers in Africa: a simulation. BMC Infect Dis 2008;8:66.
42. Lehman DA, Chung MH, John-Stewart GC, et al. HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission. AIDS 2008;22:1475-1485.
43. Creek T, Tanuri A, Smith M, et al. Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to-child transmission. Pediatr Infect Dis J 2008;27:22-26.
44. Zhang Q, Wang L, Jiang Y, et al. Early infant human immunodeficiency virus type 1 detection suitable for resource-limited settings with multiple circulating subtypes by use of nested three-monoplex DNA PCR and dried blood spots. J Clin Micrabiol 2008;46:721-726.